Current Report Filing (8-k)
January 09 2017 - 6:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2017
ARDELYX, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36485
|
|
26-1303944
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
34175 Ardenwood Blvd., Suite 100
Fremont, CA 94555
(Address of principal executive offices, including Zip Code)
Registrants telephone number, including area code:
(510) 745-1700
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On January 9, 2017, Ardelyx, Inc. (the
Company) announced that as of December 31, 2016, the Company had approximately $201 million in cash and cash equivalents.
The
information furnished under this Item 2.02 shall not be considered filed under the Securities Exchange Act of 1934, as amended (the Exchange Act), nor shall it be incorporated by reference into any future filing under the
Securities Act of 1933, as amended, or under the Exchange Act unless the Company expressly sets forth in such future filing that such information is to be considered filed or incorporated by reference therein.
Item 7.01
|
Regulation FD Disclosure.
|
Attached hereto as Exhibit 99.1 is a corporate presentation of the Company
incorporated by reference herein.
The information furnished under this Item 7.01 shall not be considered filed under the Exchange Act, nor
shall it be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or under the Exchange Act unless the Company expressly sets forth in such future filing that such information is to be considered
filed or incorporated by reference therein.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Corporate presentation of Ardelyx, Inc.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
Date: January 9, 2017
|
|
ARDELYX, INC.
|
|
|
|
|
|
By:
|
|
/s/ Mark Kaufmann
|
|
|
|
|
Mark Kaufmann
|
|
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Corporate presentation of Ardelyx, Inc.
|
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
From Apr 2023 to Apr 2024